X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1482) 1482
Publication (74) 74
Book / eBook (37) 37
Book Chapter (7) 7
Magazine Article (5) 5
Book Review (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1168) 1168
hyperkinesis - drug therapy (944) 944
male (878) 878
child (743) 743
female (547) 547
animals (436) 436
hyperkinesis - chemically induced (353) 353
index medicus (278) 278
child, preschool (274) 274
methylphenidate - therapeutic use (261) 261
adolescent (259) 259
rats (236) 236
neurosciences (229) 229
mice (192) 192
motor activity - drug effects (184) 184
adult (173) 173
hyperkinesis - etiology (172) 172
pharmacology & pharmacy (155) 155
psychiatry (153) 153
dose-response relationship, drug (151) 151
hyperkinesis - physiopathology (148) 148
disease models, animal (132) 132
clinical trials as topic (128) 128
clinical neurology (127) 127
dextroamphetamine - therapeutic use (127) 127
hyperkinesis - diagnosis (123) 123
hyperkinesis (114) 114
hyperactivity (113) 113
middle aged (112) 112
time factors (108) 108
hyperkinesis - psychology (102) 102
hyperkinesis - therapy (101) 101
behavior, animal - drug effects (94) 94
children (91) 91
rats, sprague-dawley (90) 90
placebos (89) 89
attention deficit disorder with hyperactivity - drug therapy (86) 86
schizophrenia (80) 80
child behavior disorders - drug therapy (79) 79
aged (78) 78
infant (74) 74
dopamine (73) 73
age factors (69) 69
pediatrics (69) 69
analysis of variance (68) 68
electroencephalography (68) 68
methylphenidate - adverse effects (67) 67
attention - drug effects (66) 66
attention-deficit hyperactivity disorder (64) 64
amphetamine (62) 62
hyperkinesis - complications (62) 62
hyperkinesis - metabolism (62) 62
hyperkinesis - genetics (60) 60
brain (59) 59
dopamine - metabolism (59) 59
methylphenidate - pharmacology (59) 59
schizophrenia - drug therapy (59) 59
drug therapy (58) 58
rats, wistar (56) 56
methylphenidate - administration & dosage (54) 54
amphetamine - therapeutic use (53) 53
antipsychotic agents - therapeutic use (53) 53
psychological tests (53) 53
antipsychotic agents - pharmacology (52) 52
mice, inbred c57bl (52) 52
parkinson disease - drug therapy (50) 50
behavior (48) 48
follow-up studies (48) 48
neurology (48) 48
behavior therapy (47) 47
double-blind method (47) 47
drug interactions (46) 46
treatment outcome (46) 46
drug evaluation (45) 45
attention (44) 44
diagnosis, differential (43) 43
rat (43) 43
amphetamine - pharmacology (42) 42
brain - metabolism (42) 42
analysis (41) 41
hyperkinesis - prevention & control (41) 41
locomotor activity (41) 41
methylphenidate (40) 40
mice, knockout (40) 40
article (39) 39
attention deficit disorder with hyperactivity - diagnosis (39) 39
brain - drug effects (39) 39
central nervous system stimulants - therapeutic use (39) 39
tranquilizing agents - therapeutic use (39) 39
dextroamphetamine - adverse effects (37) 37
hyperkinesia (36) 36
pregnancy (36) 36
anticonvulsants - therapeutic use (35) 35
attention-deficit/hyperactivity disorder (35) 35
central nervous system stimulants - pharmacology (35) 35
hyperactive children (35) 35
imipramine - therapeutic use (35) 35
adhd (34) 34
rodents (34) 34
dextroamphetamine - pharmacology (33) 33
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
OISE - Stacks (22) 22
Gerstein Science - Stacks (21) 21
UTL at Downsview - May be requested (5) 5
UofT at Mississauga - Stacks (5) 5
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
OISE - Lost (1) 1
Regis College - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1331) 1331
German (74) 74
Russian (43) 43
French (19) 19
Italian (10) 10
Spanish (10) 10
Japanese (9) 9
Polish (7) 7
Danish (4) 4
Czech (3) 3
Hebrew (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Dutch (2) 2
Chinese (1) 1
Finnish (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 7, pp. 1487 - 1504
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2013, Volume 33, Issue 9, pp. 3953 - 3966
Down syndrome (DS) is associated with neurological complications, including cognitive deficits that lead to impairment in intellectual functioning. Increased... 
Protein Binding - genetics | Electric Stimulation | Cell Count | Male | GABA Modulators - therapeutic use | Learning Disorders - etiology | Hyperkinesis - drug therapy | Neurogenesis - genetics | Long-Term Potentiation - drug effects | Protein Binding - drug effects | Exploratory Behavior - drug effects | Reflex, Startle - drug effects | Imidazoles - therapeutic use | Excitatory Postsynaptic Potentials - genetics | Disease Models, Animal | Mice, Transgenic | Hippocampus - pathology | Imidazoles - pharmacology | Psychomotor Performance - drug effects | Hyperkinesis - etiology | Vesicular Inhibitory Amino Acid Transport Proteins - metabolism | Analysis of Variance | Seizures - etiology | Glutamate Decarboxylase - metabolism | Mice | Receptors, GABA-A - metabolism | Benzodiazepines - therapeutic use | Tritium - pharmacokinetics | Sensory Gating - drug effects | Reflex - genetics | Reflex - drug effects | Hippocampus - drug effects | Excitatory Postsynaptic Potentials - drug effects | Ki-67 Antigen | Reaction Time - drug effects | GABA Modulators - pharmacology | Neurons - physiology | Down Syndrome - complications | Membrane Proteins - metabolism | Neurogenesis - drug effects | Neurons - drug effects | Cues | Down Syndrome - pathology | Benzodiazepines - pharmacology | Acoustic Stimulation | Mice, Inbred C57BL | Learning Disorders - drug therapy | Long-Term Potentiation - genetics | Biophysics | Maze Learning - drug effects | Rotarod Performance Test | Animals | Carrier Proteins - metabolism | Down Syndrome - drug therapy | Cell Proliferation - drug effects
Journal Article
Cerebral Cortex, ISSN 1047-3211, 2014, Volume 24, Issue 2, pp. 364 - 376
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2010, Volume 334, Issue 1, pp. 171 - 181
Journal Article
Movement Disorders, ISSN 0885-3185, 01/2007, Volume 22, Issue 2, pp. 193 - 197
We sought to review the long‐term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement... 
tetrabenazine | chorea | tics | tolerability | tardive dyskinesia | Tics | Tolerability | Tardive dyskinesia | Tetrabenazine | Chorea | OPEN-LABEL | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | TOURETTES-SYNDROME | DRUGS | NEUROLEPTIC MALIGNANT SYNDROME | DOUBLE-BLIND | TARDIVE-DYSKINESIA | HUNTINGTONS-DISEASE | BRAIN | Prevalence | Dyskinesia, Drug-Induced - physiopathology | Humans | Middle Aged | Drug Tolerance - physiology | Male | Hyperkinesis - physiopathology | Time | Hyperkinesis - drug therapy | Tics - epidemiology | Myoclonus - drug therapy | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Adult | Female | Anti-Dyskinesia Agents - administration & dosage | Retrospective Studies | Huntington Disease - physiopathology | Severity of Illness Index | Tetrabenazine - administration & dosage | Parkinsonian Disorders - physiopathology | Dyskinesia, Drug-Induced - epidemiology | Drug Administration Schedule | Parkinsonian Disorders - epidemiology | Huntington Disease - etiology | Myoclonus - physiopathology | Anti-Dyskinesia Agents - therapeutic use | Huntington Disease - epidemiology | Anti-Dyskinesia Agents - adverse effects | Age of Onset | Tetrabenazine - adverse effects | Hyperkinesis - epidemiology | Myoclonus - epidemiology | Tics - drug therapy | Tics - physiopathology | Tetrabenazine - therapeutic use
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 05/2010, Volume 27, Issue 5, pp. 911 - 921
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 01/2012, Volume 17, Issue 1, pp. 85 - 98
Dysbindin-1 regulates D2-receptor trafficking and is implicated in schizophrenia and related cognitive abnormalities, but whether this molecular effect... 
schizophrenia | genes | working memory | dopamine | mice | prefrontal cortex | PREPULSE INHIBITION | 6P22.3 GENE | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUNCTIONAL CONNECTIVITY | HIPPOCAMPAL-FORMATION | NEUROSCIENCES | GENETIC-VARIATION | PYRAMIDAL NEURONS | D2 RECEPTOR | MESSENGER-RNA | SUSCEPTIBILITY GENE | WORKING-MEMORY | Sensory Gating - drug effects | Gene Expression Regulation, Enzymologic - drug effects | Hyperkinesis - genetics | Action Potentials - genetics | Prefrontal Cortex - physiopathology | Motor Activity - drug effects | Schizophrenia - complications | Memory, Short-Term - physiology | Schizophrenia - pathology | Receptors, Dopamine D2 - metabolism | Hyperkinesis - drug therapy | Prefrontal Cortex - pathology | Prefrontal Cortex - drug effects | Dopamine Agents - pharmacology | Reaction Time - drug effects | Sensory Gating - genetics | Mice, Inbred DBA | Pyramidal Cells - drug effects | Action Potentials - drug effects | Dopamine - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism | Disease Models, Animal | Memory, Short-Term - drug effects | Amphetamine - adverse effects | Reaction Time - genetics | Maze Learning - drug effects | Hyperkinesis - etiology | Mice, Knockout | Dystrophin-Associated Proteins | Carrier Proteins - genetics | Motor Activity - genetics | Animals | Memory Disorders - drug therapy | Memory Disorders - etiology | Gene Expression Regulation, Enzymologic - genetics | Mice | Dysbindin | Stress, Psychological - physiopathology | Genetic aspects | Prefrontal cortex | Research | Binding proteins | Properties | Dopaminergic mechanisms | Genetic regulation
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 12/2015, Volume 172, Issue 12, pp. 1197 - 1206
Journal Article